Jim McGuire, CEO
Jim McGuire has over 20 years in healthcare, biotech, medtech with expertise in management, commercialisation, product and manufacturing development, project management and IP. Previously Jim has worked in life science start-ups and was recently the CEO of an NHS spin-out developing surgical devices, taking their innovations into the global market place.
Dr Graeme Deuchar, R&D Director
Graeme Deuchar has over 15 years experience working as a biomedical research professional. He has an impressive track record of developing and utilising preclinical disease models combined with imaging, in projects designed to improve understanding of disease mechanism and investigate novel diagnostic and therapeutic advances in areas of cardiovascular, pulmonary and neurological medicine. Graeme is a co-founder of Aurum Biosciences Ltd where he advises on planning the current and future research and development programme required to support continued progression of the company’s key technology. Graeme also provides regulatory affairs expertise and has experience in areas related to the regulatory requirements for the development of small molecule and biopharmaceutical medicinal products.
Dr David Brennan, Director of Project Management
David Brennan has worked as a clinical scientist for 20 years specialising in Clinical Physics. During that time he has had experience in clinical research and service development. His focus has been in the field of MRI, image analysis and their clinical applications. He is a founding researcher of Aurum Biosciences having provided significant input into the development of the imaging and image analysis. During the course of Aurum’s development David has taken a keen interest in the commercial aspects of the project. He was fortunate enough to have been a student on Cambridge University’s Ignite entrepreneurial course, and MIT’s Entrepreneurship Development Program.
Elaine Gemmell, Director of Quality and Operations
Elaine Gemmell was Director of Regulatory Affairs with Clear Surgical Limited. She was responsible for implementing BS EN ISO 13485 and 9001 and obtaining regulatory approval for the company to design, develop and manufacture sterile surgical instruments. Previously she was Senior Manager and Executive Director with Scottish Health Innovations Ltd, responsible for developing new medical technologies in partnership with NHS Scotland, industry and academia. She has overseen a range of medical device developments from initial concept through to regulatory approval and launch onto the market. She has extensive quality management experience in the medical devices field and is a Lead Auditor for BS EN ISO 13485. She has fulfilled the role of QMR and consultant for the regulatory approval of medical devices in Europe. Previously she worked in the semi-conductor industry for twenty years with experience in product engineering, field applications, design and new product introduction